The Effect of Selective Inhibition of Inducible Nitric Oxide Synthase on Cytochrome P450 After Liver Transplantation in a Rat Model

Transplantation Proceedings

Volumn 40, Issue 4, 2008, Pages 983-985

  Matevossian, E ^a   Novotny, A ^a   Knebel, C ^a   Brill, T ^a   Werner, M ^a   Sinicina, I ^b   Kriner, M ^a   Stangl, M ^a   Thorban, S ^a   Huser N ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; INDUCIBLE NITRIC OXIDE SYNTHASE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DARK AGOUTI RAT; ENZYME ACTIVITY; ENZYME INHIBITION; GRAFT RECIPIENT; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEWIS RAT; LIVER BIOPSY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL MARKERS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATION; GUANIDINES; KINETICS; LIVER TRANSPLANTATION; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE II; RATS;

EID: 44849118544     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.04.001     Document Type: Article

References (12)

1. Westerholt A., Himpel S., Hager-Gensch B., et al. Intragraft iNOS induction during human liver allograft rejection depresses cytochrome p450 activity. Transpl Int 17 (2004) 370
2. Thörn M., Lundgren S., Herlenius G., et al. Gene expression of cytochromes P450 in liver transplants over time. Eur J Clin Pharmacol 60 (2004) 413
3. Gruttadauria S., Marino G., Catalano F., et al. Correlation between cytochrome P-450 system and liver function tests during experimental liver transplantation. G Chir 21 (2000) 353
4. Kuo P.C., Alfrey E.J., Abe K.Y., et al. Cellular localization and effect of nitric oxide synthesis in a rat model of orthotopic liver transplantation. Transplantation 61 (1996) 305
5. Worrall N.K., Boasquevisque C.H., Botney M., et al. Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection. Transpl 63 (1997) 1095
6. Worrall N.K., Chang K., Suau G.M., et al. Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection. Circ Res 78 (1996) 769
7. Worrall N.K., Lazenby W.D., Misko T.P., et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 181 (1995) 63
8. Corbett J.A., Tilton R.G., Chang K., et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41 (1992) 552
9. Novotny A.R., Emmauel K., Maier S., et al. Cytochrome P450 activity mirrors nitric oxide levels in postoperative sepsis: predictive indicators of lethal outcome. Surgery 141 (2003) 376
10. Snover D.C., Freese D.K., and Sharp H.L. Liver allograft rejection. An analysis of he use of biopsy in determining outcome of rejection. Am J Surg Pathol 11 (1987) 18
11. Khandoga A., Biberthaler P., Enders G., et al. P-selectin mediates platelet-endothelal cell interactions and reperfusion injury in the mouse liver in vivo. Shock 18 (2002) 529
12. Schmitt-Sody M., Gottschalk O., Metz P., et al. Endothelial iNOS versus platelet iNOS: responsibility for the platelet/leucocyte endothelial cell interaction in murine antigen induced arthritis in vivo. Inflamm Res 56 (2007) 262